RxDoctor Payments Data

Kirtida Desai

Psychiatry · Whitfield, MSNPI 1578505715

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.7% of the total across 249 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Alkermes, Inc. at 25.4% of the total. Among psychiatry clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,294in general payments, 2019–2025

Across 249 payments — averaging $21.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alkermes, Inc.$1K
  • Neurocrine Biosciences, Inc.$674
  • Teva Pharmaceuticals USA, Inc.$655
  • Lundbeck LLC$553
  • Johnson & Johnson$504
  • Otsuka America Pharmaceutical, Inc.$447
  • plus $1K from 12 others

What the payments were for

  • Consulting fees$1753%
  • Food & beverage$5,11997%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,294 in reported general payments places this provider in the 90th percentile of 219 psychiatry providers in Mississippi.

See all psychiatry providers in Mississippi

Most prescribed under Part D

DrugClaimsCost to plans & patients
BiktarvyBictegrav/Emtricit/Tenofov Ala12$46,091
Chlorpromazine Hcl38$7,131
MyrbetriqMirabegron14$6,242
Clozapine85$6,180
Haloperidol Decanoate78$5,773
Haloperidol118$4,868
Risperidone OdtRisperidone32$4,786
Olanzapine OdtOlanzapine33$2,930
Divalproex Sodium ErDivalproex Sodium34$2,433
Divalproex Sodium81$1,933
Quetiapine Fumarate91$1,725
Atropine Sulfate31$1,519
Valproic AcidValproic Acid (As Sodium Salt)41$1,063
Aripiprazole12$752
Lithium Carbonate33$662

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Loxapine$655$34611 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 219 psychiatry providers in Mississippi.

Other psychiatry in Whitfield

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →